471 related articles for article (PubMed ID: 10670449)
21. Induction and suppression of immediate-early genes in the rat brain by a selective alpha-2-adrenoceptor agonist and antagonist following noxious peripheral stimulation.
Pertovaara A; Bravo R; Herdegen T
Neuroscience; 1993 May; 54(1):117-26. PubMed ID: 8100045
[TBL] [Abstract][Full Text] [Related]
22. Stress-induced C-fos expression in the rat locus coeruleus is dependent on neurokinin 1 receptor activation.
Hahn MK; Bannon MJ
Neuroscience; 1999; 94(4):1183-8. PubMed ID: 10625057
[TBL] [Abstract][Full Text] [Related]
23. Tachykinin NK1 receptor subtypes in the rat urinary bladder.
Meini S; Patacchini R; Maggi CA
Br J Pharmacol; 1994 Mar; 111(3):739-46. PubMed ID: 7517327
[TBL] [Abstract][Full Text] [Related]
24. Effects of intra-basolateral amygdala administration of rimonabant on nociceptive behaviour and neuronal activity in the presence or absence of contextual fear.
Roche M; Johnston P; Mhuircheartaigh ON; Olango WM; Mackie K; Finn DP
Eur J Pain; 2010 May; 14(5):487-95. PubMed ID: 19786358
[TBL] [Abstract][Full Text] [Related]
25. Further evidence that central tachykinin NK-1 receptors mediate the inhibitory effect of tachykinins on angiotensin-induced drinking in rats.
Polidori C; Ciccocioppo R; De Caro G; Massi M
Peptides; 1998; 19(1):149-55. PubMed ID: 9437747
[TBL] [Abstract][Full Text] [Related]
26. Electrocorticographic desynchronization after application of visceral and somatic noxious stimuli in urethane-anesthetized rats: effect of intrathecal administration of tachykinin (NK 1 or NK 2) receptor antagonists.
Conte B; Cutrufo C; Manzini S
J Pharmacol Exp Ther; 1996 Jan; 276(1):212-8. PubMed ID: 8558433
[TBL] [Abstract][Full Text] [Related]
27. Effects of systemic bicuculline or morphine on formalin-evoked pain-related behaviour and c-Fos expression in trigeminal nuclei after formalin injection into the lip or tongue in rats.
Sugiyo S; Uehashi D; Satoh F; Abe T; Yonehara N; Kobayashi M; Takemura M
Exp Brain Res; 2009 Jun; 196(2):229-37. PubMed ID: 19462165
[TBL] [Abstract][Full Text] [Related]
28. Intracerebroventricular responses to neuropeptide gamma in the conscious rat: characterization of its receptor with selective antagonists.
Picard P; Couture R
Br J Pharmacol; 1996 Jan; 117(2):241-9. PubMed ID: 8789375
[TBL] [Abstract][Full Text] [Related]
29. Role of tachykinin receptors in the central processing of afferent input from the acid-threatened rat stomach.
Michl T; Jocic M; Schuligoi R; Holzer P
Regul Pept; 2001 Dec; 102(2-3):119-26. PubMed ID: 11730984
[TBL] [Abstract][Full Text] [Related]
30. The ventral tegmental area as a putative target for tachykinins in cardiovascular regulation.
Deschamps K; Couture R
Br J Pharmacol; 2005 Jul; 145(6):712-27. PubMed ID: 15895109
[TBL] [Abstract][Full Text] [Related]
31. The non-peptide neurokinin-1 antagonist, RPR 100893, decreases c-fos expression in trigeminal nucleus caudalis following noxious chemical meningeal stimulation.
Cutrer FM; Moussaoui S; Garret C; Moskowitz MA
Neuroscience; 1995 Feb; 64(3):741-50. PubMed ID: 7536309
[TBL] [Abstract][Full Text] [Related]
32. Opioid activity of sendide, a tachykinin NK1 receptor antagonist.
Sakurada T; Yuhki M; Inoue M; Sakurada C; Tan-No K; Ohba M; Kisara K; Sakurada S
Eur J Pharmacol; 1999 Mar; 369(3):261-6. PubMed ID: 10225361
[TBL] [Abstract][Full Text] [Related]
33. Selective blockade of substance P or neurokinin A receptors reduces the expression of c-fos in trigeminal subnucleus caudalis after corneal stimulation in the rat.
Bereiter DA; Bereiter DF; Tonnessen BH; Maclean DB
Neuroscience; 1998 Mar; 83(2):525-34. PubMed ID: 9460760
[TBL] [Abstract][Full Text] [Related]
34. Modulation of morphine-induced Fos-immunoreactivity by the cannabinoid receptor antagonist SR 141716.
Singh ME; Verty AN; Price I; McGregor IS; Mallet PE
Neuropharmacology; 2004 Dec; 47(8):1157-69. PubMed ID: 15567425
[TBL] [Abstract][Full Text] [Related]
35. Blockade of 5-Ht3 receptors in the septal area increases Fos expression in selected brain areas.
Urzedo-Rodrigues LS; Ferreira HS; Santana RC; Luz CP; Perrone CF; Fregoneze JB
Auton Neurosci; 2014 Apr; 181():55-68. PubMed ID: 24507935
[TBL] [Abstract][Full Text] [Related]
36. Use of selective antagonists to dissociate the central cardiovascular and behavioural effects of tachykinins on NK1 and NK2 receptors in the rat.
Tschöpe C; Picard P; Culman J; Prat A; Itoi K; Regoli D; Unger T; Couture R
Br J Pharmacol; 1992 Nov; 107(3):750-5. PubMed ID: 1335337
[TBL] [Abstract][Full Text] [Related]
37. Leukocyte recruitment to peritoneal cavity of rats following formalin injection: role of tachykinin receptors.
Santos JM; Tatsuo MA; Turchetti-Maia RM; Lisboa MC; de Francischi JN
J Pharmacol Sci; 2004 Apr; 94(4):384-92. PubMed ID: 15107578
[TBL] [Abstract][Full Text] [Related]
38. Evidence for a role of tachykinins as sensory transmitters in the activation of micturition reflex.
Lecci A; Giuliani S; Garret C; Maggi CA
Neuroscience; 1993 Jun; 54(3):827-37. PubMed ID: 8101362
[TBL] [Abstract][Full Text] [Related]
39. Distinct regulations by septide and the neurokinin-1 tachykinin receptor agonist [pro9]substance P of the N-methyl-D-aspartate-evoked release of dopamine in striosome- and matrix-enriched areas of the rat striatum.
Gauchy C; Desban M; Glowinski J; Kemel ML
Neuroscience; 1996 Aug; 73(4):929-39. PubMed ID: 8809812
[TBL] [Abstract][Full Text] [Related]
40. Effect of subchronic administration of tachykinin antagonists on response of guinea-pigs to mild and severe stress.
Anderson W; Newson P; Skeri M; Janssen N; Milne S; Yip J; Jungnickel S; Lynch-Frame A; Chahl LA
Regul Pept; 2011 Jun; 168(1-3):59-68. PubMed ID: 21477621
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
